disulfiram has been researched along with carbenoxolone sodium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Baumann, B; Carragher, NO; Dahlhaus, M; Debatin, KM; Enzenmüller, S; Fischer-Posovszky, P; Föhr, KJ; Halatsch, ME; Karpel-Massler, G; Mertens, D; Mettang, M; Meyer-Pannwitt, V; Nonnenmacher, L; Schneider, EM; Siegelin, MD; Stroh, S; Westhoff, MA; Zhou, S | 1 |
2 other study(ies) available for disulfiram and carbenoxolone sodium
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Animals; Anti-Ulcer Agents; Apoptosis; Brain Neoplasms; Carbenoxolone; Cell Adhesion; Cell Proliferation; Disulfiram; Drug Therapy, Combination; Gene Expression Profiling; Glioblastoma; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplastic Stem Cells; Prognosis; Signal Transduction; Survival Rate; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |